Literature DB >> 16557931

Failure of synthetic polynucleotides to affect the immunogenicity of mycobacterial ribonucleic Acid and ribosomal protein preparations.

A S Youmans1, G P Youmans.   

Abstract

The synthetic polyribonucleotides adenylic acid (poly A), uridylic acid (poly U), cytidylic acid (poly C), and inosinic acid (poly I), whether single- or double-stranded (poly A:U, poly I:C), cannot replace mycobacterial ribonucleic acid (RNA) in the production of a high immune response in CF-1 mice against tuberculous disease. These conclusions are based on the results of several types of experiments. (i) Poly A and poly U, used either singly or in combination, did not increase the immunogenicity of mycobacterial RNA preparations whether emulsified in Freund's incomplete adjuvant (FIA) or not emulsified. (ii) Mycobacterial ribosomal protein, extracted with 2-chloroethanol, was not immunogenic; the addition of poly A:U to the protein did not produce an immune response and FIA did not affect these results. (iii) The RNA left after the protein was extracted was partially immunogenic when emulsified in FIA even though it was partially degraded. (iv) Mycobacterial RNA prepared with ethyl alcohol and partially degraded with ribonuclease had a significantly lower immunogenic activity, and the original higher immune response was not restored by the addition of poly A:U. (v) Mycobacterial RNA totally degraded by weak alkali was not immunogenic, the original immunogenic activity was not restored by the addition of poly A:U or poly I:C, and FIA again did not influence the results. These findings suggest that (i) protein, polypeptides, or other antigenic fragments, if present, are not the specific immunogens; and (ii) mycobacterial RNA is responsible for the high immunogenic activity of mycobacterial ribosomal and RNA preparations. In addition, since the double-stranded forms of these synthetic polynucleotides markedly potentiate the formation of circulating antibodies, these results also reemphasize the lack of correlation between conventional antibody formation and immunity against tuberculosis.

Entities:  

Year:  1971        PMID: 16557931      PMCID: PMC416120          DOI: 10.1128/iai.3.1.149-153.1971

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  REPLICATION OF VIRAL RNA, III. DOUBLE-STRANDED REPLICATIVE FORM OF MSW PHAGE RNA.

Authors:  C WEISSMANN; P BORST; R H BURDON; M A BILLETER; S OCHOA
Journal:  Proc Natl Acad Sci U S A       Date:  1964-04       Impact factor: 11.205

2.  IMMUNOGENICITY OF ANTIGEN-CONTAINING RIBONUCLEIC ACID PREPARATIONS FROM MACROPHAGES.

Authors:  B A ASKONAS; J M RHODES
Journal:  Nature       Date:  1965-01-30       Impact factor: 49.962

3.  STUDIES ON THE ADJUVANT ACTION OF BACTERIAL ENDOTOXINS ON ANTIBODY FORMATION. VI. ENHANCEMENT OF ANTIBODY FORMATION BY NUCLEIC ACIDS.

Authors:  K MERRITT; A G JOHNSON
Journal:  J Immunol       Date:  1965-03       Impact factor: 5.422

4.  Studies on the formation of two- and three-stranded polyribonucleotides.

Authors:  G FELSENFELD; A RICH
Journal:  Biochim Biophys Acta       Date:  1957-12

5.  THE SECONDARY STRUCTURE OF REOVIRUS RNA.

Authors:  P J Gomatos; I Tamm
Journal:  Proc Natl Acad Sci U S A       Date:  1963-05       Impact factor: 11.205

6.  Macrophage ribonucleoprotein: nature of the antigenic fragment.

Authors:  A A Gottlieb
Journal:  Science       Date:  1969-08-08       Impact factor: 47.728

7.  Induction in vitro of antibodies to phage T2: antigens in the RNA extract employed.

Authors:  H P Friedman; A B Stavitsky; J M Solomon
Journal:  Science       Date:  1965-09-03       Impact factor: 47.728

8.  The measurement of the response of immunized mice to infection with Mycobacterium tuberculosis va. hominis.

Authors:  G P YOUMANS; A S YOUMANS
Journal:  J Immunol       Date:  1957-05       Impact factor: 5.422

9.  Immunogenic mycobacterial ribosomal and ribonucleic Acid preparations: chemical and physical characteristics.

Authors:  A S Youmans; G P Youmans
Journal:  Infect Immun       Date:  1970-11       Impact factor: 3.441

10.  Antibody formation: stimulation by polyadenylic and polycytidylic acids.

Authors:  W Braun; M Nakano
Journal:  Science       Date:  1967-08-18       Impact factor: 47.728

View more
  10 in total

1.  Immunogenicity of ribosomes from enzymatically lysed Streptococcus pyogenes.

Authors:  B A Green; W Johnson
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

2.  Protection against Toxoplasma gondii in mice immunized with Toxoplasma cell fractions, RNA and synthetic polyribonucleotides.

Authors:  F G Araujo; J S Remington
Journal:  Immunology       Date:  1974-10       Impact factor: 7.397

3.  Ribosomal vaccines. II. Specificity of the immune response to ribosomal ribonucleic acid and protein isolated from Salmonella typhimurium.

Authors:  W Johnson
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

4.  Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenes.

Authors:  W O Schalla; W Johnson
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

5.  Variability of protection in inbred mice induced by a ribosomal vaccine prepared from Salmonella typhimurium.

Authors:  M L Misfeldt; W Johnson
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

6.  Immunity to Salmonella typhimurium infection: characterization of antigens in active protection by polyacrylamide gel electrophoresis.

Authors:  D P Houchens; G L Wright
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

7.  Immunogenicity of Ribosomal Preparations from Yeast Cells of Histoplasma capsulatum.

Authors:  C Feit; R P Tewari
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

8.  Ribonucleic acid-protein fractions of virulent Salmonella typhimurium as protective immunogens.

Authors:  R A Smith; N J Bigley
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

9.  Ribosomal vaccines. I. Immunogenicity of ribosomal fractions isolated from Salmonella typhimurium and Yersinia pestis.

Authors:  W Johnson
Journal:  Infect Immun       Date:  1972-06       Impact factor: 3.441

10.  Purification of immunogenically active ribonucleic acid preparations of Salmonella typhimurium: molecular-sieve and anion-exchange chromatography.

Authors:  M R Venneman
Journal:  Infect Immun       Date:  1972-03       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.